The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective validation of end of treatment ctDNA-MRD by PhasED-Seq in DLBCL patients from a national trial.
 
Steven Wang
No Relationships to Disclose
 
Marcel Nijland
No Relationships to Disclose
 
Leonie Strobbe
No Relationships to Disclose
 
Margreet Oosterveld
No Relationships to Disclose
 
Rinske Boersma
No Relationships to Disclose
 
Harry Koene
No Relationships to Disclose
 
Clara Klerk
No Relationships to Disclose
 
Eva de Jongh
No Relationships to Disclose
 
Ad Koster
No Relationships to Disclose
 
Hans Pruijt
No Relationships to Disclose
 
Marjolein van der Poel
No Relationships to Disclose
 
Erik van Werkhoven
No Relationships to Disclose
 
Avinash Dinmohamed
No Relationships to Disclose
 
Sandra Close
Employment - Foresight Diagnostics
Leadership - Foresight Diagnostics
 
Krystal Brown
Employment - Foresight Diagnostics
 
Stephanie Meek
Employment - Foresight Diagnostics
Stock and Other Ownership Interests - Pfizer (I)
 
Ash Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CARGO Therapeutics; CARGO Therapeutics; CiberMed; Foresight Diagnostics
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Cibermed; Foresight Diagnostics; Foresight Diagnostics; Foresight Diagnostics; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
David Kurtz
Employment - Foresight Diagnostics
Leadership - Foresight Diagnostics
Stock and Other Ownership Interests - Foresight Diagnostics
Patents, Royalties, Other Intellectual Property - Foresight Diagnostics
 
Martine Chamuleau
Consulting or Advisory Role - Abbvie; Byondis; Incyte; Novartis
Research Funding - Bristol-Myers Squibb/Celgene; Genmab; Gilead Sciences
Patents, Royalties, Other Intellectual Property - Genmab